Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
- PMID: 24763132
- DOI: 10.1136/gutjnl-2014-306977
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
Abstract
Background and objective: Precore (PC) variant (G1896A) and basal core promoter (BCP) variant (A1762T/G1764A) of HBV are associated with risk of hepatocellular carcinoma in HBV carriers. However, little is known about their impact on the adverse outcomes of hepatitis B e antigen (HBeAg)-negative hepatitis and liver cirrhosis.
Methods: 251 spontaneous HBeAg seroconverters who had genotype B or C infection and received a long-term follow-up were enrolled. PC and BCP mutants were determined qualitatively and quantitatively to correlate with these adverse outcomes. The findings were validated by an independent case-control study, which included 184 patients with biopsy-proven liver fibrosis stages.
Results: In the longitudinal cohort study, BCP mutant and possibly PC wild type were associated with cirrhosis development, but not HBeAg-negative hepatitis. Multivariable analysis showed that only BCP mutant was an independent risk factor for cirrhosis development. Using quantitative analysis of BCP mutant, a higher proportion of BCP mutant, defined as a continuous variable, a dichotomous variable or an ordinal variable, was associated with a higher risk of cirrhosis. If we chose 45% of BCP mutant as the cut-off, the risk of cirrhosis was higher in patients with BCP mutant ≥45% compared to <45% in the longitudinal cohort; this finding was validated by the case-control study (adjusted OR: 2.81, 95% CI 1.40 to 5.67).
Conclusions: A higher proportion of BCP mutant increases the risk of liver cirrhosis development in HBV carriers with genotype B or C infection.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Comment in
-
Viral factors and predicting disease outcomes in chronic hepatitis B.Gut. 2015 Feb;64(2):191-3. doi: 10.1136/gutjnl-2014-307398. Epub 2014 Jun 11. Gut. 2015. PMID: 24920075 No abstract available.
Similar articles
-
[Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].Zhonghua Gan Zang Bing Za Zhi. 2012 Sep;20(9):644-8. doi: 10.3760/cma.j.issn.1007-3418.2012.09.002. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23207226 Chinese.
-
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.Hepatology. 2013 Mar;57(3):934-43. doi: 10.1002/hep.26121. Epub 2013 Feb 7. Hepatology. 2013. PMID: 23112104 Clinical Trial.
-
Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.J Med Virol. 2006 Aug;78(8):1047-54. doi: 10.1002/jmv.20661. J Med Virol. 2006. PMID: 16789012
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
-
The clinical implications of hepatitis B virus genotype: Recent advances.J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:123-30. doi: 10.1111/j.1440-1746.2010.06541.x. J Gastroenterol Hepatol. 2011. PMID: 21199523 Review.
Cited by
-
Unfolding the mechanism of hepatocyte injury of HBV precore and core promoter variants.Hepatology. 2023 Sep 1;78(3):702-705. doi: 10.1097/HEP.0000000000000400. Epub 2023 Apr 11. Hepatology. 2023. PMID: 37036194 Free PMC article. No abstract available.
-
Full-Length Genome Sequencing and Analysis of Hepatitis B Viruses Isolated from Iraqi Patients.Int J Microbiol. 2024 Apr 29;2024:6826495. doi: 10.1155/2024/6826495. eCollection 2024. Int J Microbiol. 2024. PMID: 38716461 Free PMC article.
-
HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative.JHEP Rep. 2023 Nov 4;6(1):100956. doi: 10.1016/j.jhepr.2023.100956. eCollection 2024 Jan. JHEP Rep. 2023. PMID: 38089551 Free PMC article.
-
Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2125-2129. doi: 10.22034/APJCP.2018.19.8.2125. Asian Pac J Cancer Prev. 2018. PMID: 30139211 Free PMC article.
-
Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection.Vaccines (Basel). 2021 Jul 31;9(8):841. doi: 10.3390/vaccines9080841. Vaccines (Basel). 2021. PMID: 34451966 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical